SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: Mike da bear who wrote (243792)6/3/2003 4:52:37 PM
From: Horgad  Read Replies (1) | Respond to of 436258
 
Don't forget to factor in the tax dollars that go towards drug research. IE in some cases, we pay for the research in tax dollars and then get gouged again with higher prescription costs.



To: Mike da bear who wrote (243792)6/3/2003 5:29:35 PM
From: Knighty Tin  Respond to of 436258
 
Mike, It drives me nuts. Tip talked about paying for other Americans, but subsidizing foreigners really makes no sense. But the counter-argument is that the American drug cos. dominate the world, they employ Americans, they pay leases for buildings, etc. Is it worth the subsidy to foreigners to dominate this industry? I have no idea what the cost/benefit analysis looks like.



To: Mike da bear who wrote (243792)6/4/2003 7:53:01 AM
From: Bill/WA  Respond to of 436258
 
Mike

<<While in Canada or other countries, the governments there regulate the drug price.>>

The US Government operates on a "Do as I say, not as I do" attitude...example; I get my med's from the VA (one of the few government entities that "sometimes" tries to control cost). The last batch I got from them were purchased from an outfit in Canada.

Bill/WA (or Will/CO)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News